JP2011505371A5 - - Google Patents

Download PDF

Info

Publication number
JP2011505371A5
JP2011505371A5 JP2010536173A JP2010536173A JP2011505371A5 JP 2011505371 A5 JP2011505371 A5 JP 2011505371A5 JP 2010536173 A JP2010536173 A JP 2010536173A JP 2010536173 A JP2010536173 A JP 2010536173A JP 2011505371 A5 JP2011505371 A5 JP 2011505371A5
Authority
JP
Japan
Prior art keywords
cancer
seq
chain variable
variable region
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010536173A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011505371A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/084899 external-priority patent/WO2009073524A2/en
Publication of JP2011505371A publication Critical patent/JP2011505371A/ja
Publication of JP2011505371A5 publication Critical patent/JP2011505371A5/ja
Withdrawn legal-status Critical Current

Links

JP2010536173A 2007-11-30 2008-11-26 抗−rg−1抗体の複合体 Withdrawn JP2011505371A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99169007P 2007-11-30 2007-11-30
PCT/US2008/084899 WO2009073524A2 (en) 2007-11-30 2008-11-26 Conjugates of anti-rg-1 antibodies

Publications (2)

Publication Number Publication Date
JP2011505371A JP2011505371A (ja) 2011-02-24
JP2011505371A5 true JP2011505371A5 (https=) 2011-11-04

Family

ID=40427118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010536173A Withdrawn JP2011505371A (ja) 2007-11-30 2008-11-26 抗−rg−1抗体の複合体

Country Status (18)

Country Link
US (1) US20110020329A1 (https=)
EP (1) EP2211908A2 (https=)
JP (1) JP2011505371A (https=)
KR (1) KR20100101122A (https=)
CN (1) CN101951960A (https=)
AR (1) AR069746A1 (https=)
AU (1) AU2008331507A1 (https=)
BR (1) BRPI0819765A2 (https=)
CA (1) CA2707443A1 (https=)
CL (1) CL2008003525A1 (https=)
CO (1) CO6210734A2 (https=)
EA (1) EA201000921A1 (https=)
IL (1) IL206060A0 (https=)
MX (1) MX2010005683A (https=)
NZ (1) NZ586514A (https=)
TW (1) TW200930407A (https=)
WO (1) WO2009073524A2 (https=)
ZA (1) ZA201003729B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005263555B2 (en) * 2004-07-16 2011-01-27 Amgen Research (Munich) Gmbh Expression-enhanced polypeptides
ES2647317T3 (es) 2008-11-03 2017-12-20 Syntarga B.V. Análogos de CC-1065 y sus conjugados
PT3056203T (pt) 2010-04-21 2018-02-15 Syntarga Bv Conjugados de análogos de cc-1065 e ligantes bifuncionais
EP2576621B1 (en) 2010-05-27 2019-04-10 Genmab A/S Monoclonal antibodies against her2
CA2800769C (en) 2010-05-27 2021-11-02 Genmab A/S Monoclonal antibodies against her2 epitope
US8852599B2 (en) * 2011-05-26 2014-10-07 Bristol-Myers Squibb Company Immunoconjugates, compositions for making them, and methods of making and use
RU2680404C2 (ru) 2014-01-10 2019-02-21 Синтон Байофармасьютикалс Б. В. Способ очистки cys-связанных конъюгатов антитело-лекарственное средство
US10562977B2 (en) * 2014-01-29 2020-02-18 Shanghai Hengrui Pharmaceutical Co., Ltd. Ligand-cytotoxic drug conjugate, preparation method thereof, and uses thereof
MY202018A (en) 2017-07-31 2024-03-29 Trishula Therapeutics Inc Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
US4978757A (en) * 1984-02-21 1990-12-18 The Upjohn Company 1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds
US5332837A (en) * 1986-12-19 1994-07-26 The Upjohn Company CC-1065 analogs
US5084468A (en) * 1988-08-11 1992-01-28 Kyowa Hakko Kogyo Co., Ltd. Dc-88a derivatives
JP2598116B2 (ja) * 1988-12-28 1997-04-09 協和醗酵工業株式会社 新規物質dc113
US5187186A (en) * 1989-07-03 1993-02-16 Kyowa Hakko Kogyo Co., Ltd. Pyrroloindole derivatives
JP2510335B2 (ja) * 1989-07-03 1996-06-26 協和醗酵工業株式会社 Dc―88a誘導体
CA2078118C (en) * 1990-04-25 1999-11-16 Paul A. Aristoff Cc-1065 analogs
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
US5641780A (en) * 1994-04-22 1997-06-24 Kyowa Hakko Kogyo Co., Ltd. Pyrrolo-indole derivatives
JPH07309761A (ja) * 1994-05-20 1995-11-28 Kyowa Hakko Kogyo Co Ltd デュオカルマイシン誘導体の安定化法
US5871969A (en) * 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
US6989452B2 (en) * 2001-05-31 2006-01-24 Medarex, Inc. Disulfide prodrugs and linkers and stabilizers useful therefor
EP1423110A4 (en) * 2001-09-07 2005-04-27 Scripps Research Inst CBI ANALOGUE OF CC-1065 AND DUOCARMYCINES
US7091186B2 (en) * 2001-09-24 2006-08-15 Seattle Genetics, Inc. p-Amidobenzylethers in drug delivery agents
MXPA06000798A (es) * 2003-07-22 2006-04-07 Schering Ag Anticuerpos de rg1 y usos de los mismos.
JP4806680B2 (ja) * 2004-05-19 2011-11-02 メダレックス インコーポレイテッド 自己犠牲リンカー及び薬剤複合体
US7691962B2 (en) * 2004-05-19 2010-04-06 Medarex, Inc. Chemical linkers and conjugates thereof
US7714016B2 (en) * 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
EP2354163A3 (en) * 2005-09-26 2013-04-24 Medarex, Inc. Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies
WO2007059404A2 (en) * 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
ES2469676T3 (es) * 2006-05-25 2014-06-18 Bayer Intellectual Property Gmbh Complejos moleculares dim�ricos

Similar Documents

Publication Publication Date Title
JP2011505371A5 (https=)
ES2982012T3 (es) Materiales biológicos y usos de los mismos
RU2476441C2 (ru) Cd19-связывающие средства и их применение
JP2020502271A5 (https=)
JP2009505676A5 (https=)
JP2009506790A5 (https=)
JP2010535713A5 (https=)
JP2018070648A5 (https=)
JP2010531140A5 (https=)
WO2021248048A9 (en) Antibody-drug conjugates containing an anti-mesothelin antibody and uses thereof
RU2013142004A (ru) Конъюгаты "антитело-лекарственное средство"
JP2015534579A5 (https=)
JP2015527318A5 (https=)
JP2014502955A5 (https=)
JP2013518912A5 (https=)
JP2012522513A5 (https=)
CA2595610A1 (en) Antibodies directed to angiopoietin-2 and uses thereof
JP2015528818A5 (https=)
JP2015534577A5 (https=)
JP2004534020A5 (https=)
JP2016503295A5 (https=)
JP2015534578A5 (https=)
JP2017534253A5 (https=)
JP2010511388A5 (https=)
JP2014522850A5 (https=)